Belpointe Asset Management LLC Dynavax Technologies Corp Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$9.44 - $11.88 $547 - $689
58 Added 21.48%
328 $3,000
Q4 2022

Feb 08, 2023
BUY
$10.27 - $13.29 $2,772 - $3,588
270 New
270 $2,000
Q3 2020

Nov 13, 2020
SELL
$4.32 - $11.7 $48,552 - $131,496
-11,239 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$2.94 - $9.1 $33,042 - $102,274
11,239 New
11,239 $100,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.61B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email